Loading clinical trials...
Loading clinical trials...
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety of Lenvatinib Monotherapy or Lenvatinib Combination Regimen or Comparator Treatment Arm to Cancer Patients in Eisai Sponsored Lenvatinib Trials
Conditions
Interventions
E7080
Comparator Drug
+1 more
Locations
28
United States
Harbor UCLA Medical Center
Torrance, California, United States
Northwestern University
Chicago, Illinois, United States
Karmanos Cancer Institute
Detroit, Michigan, United States
The Alfred Hospital
Melbourne, Australia
UZ Antwerpen
Edegem, Antwerpen, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Brussels Capital, Belgium
Start Date
August 16, 2018
Primary Completion Date
December 21, 2023
Completion Date
December 21, 2023
Last Updated
January 7, 2025
NCT07489378
NCT07181681
NCT07360314
NCT07204340
NCT07539285
NCT07403721
Lead Sponsor
Eisai Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions